Trial Site Detail

 

Drug:
DCC-3116 + Ripretinib
Trial:
A Study of DCC-3116 in Combination with Anticancer Therapies in Participants with Advanced Malignancies
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Instituto Europeo di Oncologia

Via Giuseppe Ripamonti, 43     
Milano , 20141
Italy

 

Principal Investigator:
 Elisabetta Setola, MD
Contact:
 Elisabetta Setola, MD +39 02 57489438 Elisabetta.setola@ieo.it
Activation Status of this Site:
 Active
Notes about this Site:
Instituto Europeo di Oncologia Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.